Target intelligence / Profile preview

Popeye domain-containing protein 2 (POPDC2)

Target
POPDC2
Molecular classification
Other (novel cAMP effector protein), Transmembrane protein
01

Overview

Popeye domain-containing protein 2 (POPDC2) is a transmembrane protein predominantly expressed in cardiac and skeletal muscle, belonging to the Popeye (POP) gene family, which also includes POPDC1 and POPDC3[1][2][4]. It contains three transmembrane domains and a cytoplasmic Popeye domain, which binds cyclic AMP (cAMP) with high affinity and mediates cAMP-dependent signaling[2][6]. POPDC2 plays a critical role in maintaining normal heart rhythm by regulating heart rate dynamics, primarily through modulating the surface expression and function of the two-pore domain potassium channel TREK-1, thereby influencing cardiac pacemaking and conduction[1][2][6]. Mutations or loss of function in POPDC2 cause stress-dependent bradyarrhythmia and inherited arrhythmia both in animal models and human disease, and are also associated with limb-girdle muscular dystrophy type 2X[1][2][4]. POPDC2 may interact with additional cAMP pathway proteins (e.g., PDE4, adenylyl cyclase 9), indicating a broader role in cyclic nucleotide signaling beyond ion channel regulation[4][6]. No approved drugs currently target POPDC2 directly, but its function highlights potential relevance for arrhythmia and muscle disease research and therapy.

Other names
Popeye domain cAMP effector 2POP2Popeye protein 2popeye domain containing 2
02

Mechanism of action

Modulates potassium channel (TREK-1) surface expression and current density via cAMP binding; functions as a cAMP effector protein relevant to signaling pathways in cardiac and skeletal muscle[1][2][6]

03

Biological functions

Signal transductionRegulation of cardiac pacemaking and conductionModulation of ion channel traffickingSkeletal muscle development and function
04

Disease associations

Cardiovascular disease (notably sinoatrial node dysfunction, arrhythmia)Muscular dystrophy (autosomal recessive limb-girdle muscular dystrophy type 2X)
05

Safety considerations

None directly reported; loss of function mutations lead to cardiac arrhythmias and muscle dystrophy, indicating that modifying POPDC2 activity may risk cardiac rhythm or muscle function[1][2][4]
06

Biomarkers

Potential biomarker for inherited arrhythmia (sinoatrial node disease) and limb-girdle muscular dystrophy, but not established in clinical practice[1][4]

Beyond the preview

Go deeper on Popeye domain-containing protein 2 (POPDC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Popeye domain-containing protein 2 (POPDC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call